Drug misuse and dependency

Services

Drugs Test 1 (DT1) form

Form for the testing of specified class A drugs on persons ages 18 or over.

Controlled drugs list
- Guidance
- 8 August 2022
- Home Office
Drug misuse and dependence: UK guidelines on clinical management
- Guidance
- 15 December 2017
- Department of Health and Social Care
ASSIST-Lite screening tool: how to use
- Guidance
- 7 April 2021
- Closed organisation: Public Health England
Recovery support services and lived experience initiatives
- Guidance
- 10 October 2024
- Office for Health Improvement and Disparities
Extra funding for drug and alcohol treatment: 2023 to 2025
- Guidance
- 16 February 2023
- Office for Health Improvement and Disparities

ACMD advice on reform to hemp licensing fees
- 23 October 2024
- Advisory Council on the Misuse of Drugs
- Correspondence
Virtual reality and wearable technology pilot to cut drug deaths
- 18 October 2024
- Department of Health and Social Care, Office for Life Sciences, and Department for Science, Innovation and Technology
- Press release
Britain takes decisive action to ban 'zombie drug' xylazine
- 4 September 2024
- Home Office
- News story
Licensed drug testing continues at music festivals this summer
- 24 May 2024
- Home Office
- News story
Government response to the ACMD's report on novel benzodiazepines
- 14 May 2024
- Home Office and Advisory Council on the Misuse of Drugs
- Correspondence

Drug misuse in England and Wales: year ending March 2024
- 12 December 2024
- Office for National Statistics
- Official statistics
IPS for alcohol and drug dependence: data linkage outcomes
- 11 December 2024
- Office for Health Improvement and Disparities
- Research
People who inject drugs: HIV and viral hepatitis monitoring
- 11 December 2024
- UK Health Security Agency
- Research
Substance misuse treatment for adults: statistics 2023 to 2024
- 28 November 2024
- Office for Health Improvement and Disparities
- National statistics
Substance misuse treatment for young people: 2023 to 2024
- 28 November 2024
- Office for Health Improvement and Disparities
- National statistics

Proposals to expand access to take-home naloxone supplies
- 14 May 2024
- Department of Health and Social Care, Department of Health (Northern Ireland), The Scottish Government, and Welsh Government
- Consultation outcome
- Date closed 06 March 2024
Expanding access to naloxone
- 24 January 2024
- Department of Health and Social Care
- Consultation outcome
- Date closed 28 September 2021
Drug prevention policies and landscape across the UK
- 5 January 2024
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence
ACMD internet-facilitated drug markets review
- 20 December 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence
Drug use in ethnic minority groups
- 21 September 2023
- Home Office and Advisory Council on the Misuse of Drugs
- Closed call for evidence

Drug Testing on Arrest (DToA): programme data
- 21 August 2024
- Home Office
- Transparency
From harm to hope: first annual report 2022 to 2023
- 27 February 2024
- Home Office
- Corporate report
Rough sleeping drug and alcohol treatment grant: privacy notice
- 22 July 2022
- Office for Health Improvement and Disparities
- Corporate report
Doctor licensing for diamorphine prescribing: privacy notice
- 22 July 2022
- Office for Health Improvement and Disparities
- Corporate report
Individual Placement and Support (IPS-AD) trial: privacy notice
- 28 January 2022
- Office for Health Improvement and Disparities
- Corporate report